Business
Sunniva Inc. President Leith Pedersen to Present at the 2nd Annual Canaccord Genuity Cannabis Conference in New York on May 17th
Sunniva Inc. President Leith Pedersen to Present at the 2nd Annual Canaccord Genuity Cannabis Conference in New York on May 17th.
About this update from Sunniva Inc
[{"type":"text","content":"\nVANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Sunniva Inc. (\"Sunniva\" or the “Company\") (CSE:SNN) (OTCQX:SNNVF) is pleased to announce that its President Leith Pedersen will be presenting at the 2nd annual Canaccord Genuity Cannabis Conference at the Westin Grand Central in New York, New York, on May 17, 2018 at 11:20 am, EST.\n Mr. Pedersen will be presenting Sunniva’s growth strategy, including its recently announced strategic acquisition of land and commencement of construction, for the Sunniva Canada Campus. The Corporate Presentation will be webcast live through the following link: http://wsw.com/webcast/canaccord31/snn.cn/ The link will be available for 90 days following the conference. About Sunniva Inc. Sunniva, through its subsidiaries, is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – where we are committed to delivering safe, high-quality products and services at scale. Our vision is to become the lowest cost, highest quality cannabis producer in the markets we serve by building large scale purpose-built current Good Manufacturing Practices (“cGMP”) greenhouses, offering better quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc. (\"SMI\") – SMI is a late stage Access Cannabis for Medical Purposes Regulations (“ACMPR”) applicant in final review and is building the Sunniva Canada Campus, 700,000 square feet of purpose-built cGMP compliant greenhouse facilities in British Columbia. The total campus is expected to produce over 100,000 kg of premium medical cannabis a year and over 25,000 kg of trim used for extraction. The facility will produce pesticide free products and will convert trim to extracted products such as cannabis oil. The oil can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams. As the facilit...